Thierry Chauche

Thierry Chauche is an accomplished financial executive with extensive experience in senior leadership roles within the biotechnology and pharmaceutical sectors. Currently serving as Chief Financial Officer at Sagimet Biosciences, Thierry has previously held CFO positions at Provention Bio, where responsibilities included leading finance and IT teams to support market creation and transformational launches, and at Alexion Pharmaceuticals, where oversight included global budgeting, financial performance analysis, and investment prioritization. Prior roles at Intercept Pharmaceuticals and Novartis Pharmaceuticals involved leading financial planning and analysis functions, business partnering, and managing key performance metrics. Thierry holds an MBA in Finance/Healthcare from The Wharton School and an MBA from Collège des Ingénieurs.